Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria – A Model for Mosquito-Borne Diseases
This grant funds research and development of next-generation malaria vaccines, serving as a model for addressing mosquito-borne diseases.
About this program
The grant aims to accelerate the research and development of innovative malaria vaccines, which are crucial in the fight against malaria and other mosquito-borne diseases. It is designed for researchers and organizations focused on vaccine development, particularly those with expertise in infectious diseases and immunology. The program supports projects that demonstrate a clear pathway to developing effective vaccines that can be deployed in affected regions. Eligible applicants include academic institutions, nonprofit organizations, and private sector entities engaged in health research. The grant encourages collaboration among various stakeholders to enhance the effectiveness of vaccine development efforts. By providing funding, the program seeks to foster advancements in vaccine technology and ultimately contribute to the reduction of malaria incidence globally.
Eligibility
Academic institutions, nonprofit organizations, and private sector entities engaged in health research.
Requirements
- Demonstrated expertise in infectious diseases
- Clear pathway to vaccine development